Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β-catenin modulator Annexin A1.

Rubinstein MR, Baik JE, Lagana SM, Han RP, Raab WJ, Sahoo D, Dalerba P, Wang TC, Han YW.

EMBO Rep. 2019 Apr;20(4). pii: e47638. doi: 10.15252/embr.201847638. Epub 2019 Mar 4.

PMID:
30833345
2.

A cluster robustness score for identifying cell subpopulations in single cell gene expression datasets from heterogeneous tissues and tumors.

Kanter I, Dalerba P, Kalisky T.

Bioinformatics. 2019 Mar 15;35(6):962-971. doi: 10.1093/bioinformatics/bty708.

PMID:
30165506
3.

The Dynamic Identity of Intestinal Cancer Stem Cells.

Dalerba P.

Cell Stem Cell. 2017 Jun 1;20(6):743-745. doi: 10.1016/j.stem.2017.05.018.

4.

A Quiescent Bcl11b High Stem Cell Population Is Required for Maintenance of the Mammary Gland.

Cai S, Kalisky T, Sahoo D, Dalerba P, Feng W, Lin Y, Qian D, Kong A, Yu J, Wang F, Chen EY, Scheeren FA, Kuo AH, Sikandar SS, Hisamori S, van Weele LJ, Heiser D, Sim S, Lam J, Quake S, Clarke MF.

Cell Stem Cell. 2017 Feb 2;20(2):247-260.e5. doi: 10.1016/j.stem.2016.11.007. Epub 2016 Dec 29.

5.

Organoid Culture of Human Cancer Stem Cells.

Shimono Y, Mukohyama J, Isobe T, Johnston DM, Dalerba P, Suzuki A.

Methods Mol Biol. 2016 Sep 22. [Epub ahead of print]

PMID:
27654995
6.

CDX2 as a Prognostic Biomarker in Colon Cancer.

Dalerba P, Sahoo D, Clarke MF.

N Engl J Med. 2016 Jun 2;374(22):2184. doi: 10.1056/NEJMc1602584. No abstract available.

7.

CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.

Dalerba P, Sahoo D, Paik S, Guo X, Yothers G, Song N, Wilcox-Fogel N, Forgó E, Rajendran PS, Miranda SP, Hisamori S, Hutchison J, Kalisky T, Qian D, Wolmark N, Fisher GA, van de Rijn M, Clarke MF.

N Engl J Med. 2016 Jan 21;374(3):211-22. doi: 10.1056/NEJMoa1506597.

8.

EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide.

Cominelli M, Grisanti S, Mazzoleni S, Branca C, Buttolo L, Furlan D, Liserre B, Bonetti MF, Medicina D, Pellegrini V, Buglione M, Liserre R, Pellegatta S, Finocchiaro G, Dalerba P, Facchetti F, Pizzi M, Galli R, Poliani PL.

J Natl Cancer Inst. 2015 Mar 3;107(5). pii: djv041. doi: 10.1093/jnci/djv041. Print 2015 May.

PMID:
25739547
9.

miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway.

Isobe T, Hisamori S, Hogan DJ, Zabala M, Hendrickson DG, Dalerba P, Cai S, Scheeren F, Kuo AH, Sikandar SS, Lam JS, Qian D, Dirbas FM, Somlo G, Lao K, Brown PO, Clarke MF, Shimono Y.

Elife. 2014 Nov 18;3. doi: 10.7554/eLife.01977.

10.

Quantitative assessment of single-cell RNA-sequencing methods.

Wu AR, Neff NF, Kalisky T, Dalerba P, Treutlein B, Rothenberg ME, Mburu FM, Mantalas GL, Sim S, Clarke MF, Quake SR.

Nat Methods. 2014 Jan;11(1):41-6. doi: 10.1038/nmeth.2694. Epub 2013 Oct 20.

11.

Oncogenic miRNAs and the perils of losing control of a stem cell's epigenetic identity.

Dalerba P, Clarke MF.

Cell Stem Cell. 2013 Jul 3;13(1):5-6. doi: 10.1016/j.stem.2013.06.012.

12.

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors.

Willingham SB, Volkmer JP, Gentles AJ, Sahoo D, Dalerba P, Mitra SS, Wang J, Contreras-Trujillo H, Martin R, Cohen JD, Lovelace P, Scheeren FA, Chao MP, Weiskopf K, Tang C, Volkmer AK, Naik TJ, Storm TA, Mosley AR, Edris B, Schmid SM, Sun CK, Chua MS, Murillo O, Rajendran P, Cha AC, Chin RK, Kim D, Adorno M, Raveh T, Tseng D, Jaiswal S, Enger PØ, Steinberg GK, Li G, So SK, Majeti R, Harsh GR, van de Rijn M, Teng NN, Sunwoo JB, Alizadeh AA, Clarke MF, Weissman IL.

Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6662-7. doi: 10.1073/pnas.1121623109. Epub 2012 Mar 26.

13.

Identification of a cKit(+) colonic crypt base secretory cell that supports Lgr5(+) stem cells in mice.

Rothenberg ME, Nusse Y, Kalisky T, Lee JJ, Dalerba P, Scheeren F, Lobo N, Kulkarni S, Sim S, Qian D, Beachy PA, Pasricha PJ, Quake SR, Clarke MF.

Gastroenterology. 2012 May;142(5):1195-1205.e6. doi: 10.1053/j.gastro.2012.02.006. Epub 2012 Feb 11.

14.

Single-cell dissection of transcriptional heterogeneity in human colon tumors.

Dalerba P, Kalisky T, Sahoo D, Rajendran PS, Rothenberg ME, Leyrat AA, Sim S, Okamoto J, Johnston DM, Qian D, Zabala M, Bueno J, Neff NF, Wang J, Shelton AA, Visser B, Hisamori S, Shimono Y, van de Wetering M, Clevers H, Clarke MF, Quake SR.

Nat Biotechnol. 2011 Nov 13;29(12):1120-7. doi: 10.1038/nbt.2038.

15.

Blood-cell banking for workers at the Fukushima Daiichi nuclear power plant.

Dalerba P.

Lancet. 2011 Aug 6;378(9790):485. doi: 10.1016/S0140-6736(11)61249-X. No abstract available.

PMID:
21821183
16.

Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models.

Liu H, Patel MR, Prescher JA, Patsialou A, Qian D, Lin J, Wen S, Chang YF, Bachmann MH, Shimono Y, Dalerba P, Adorno M, Lobo N, Bueno J, Dirbas FM, Goswami S, Somlo G, Condeelis J, Contag CH, Gambhir SS, Clarke MF.

Proc Natl Acad Sci U S A. 2010 Oct 19;107(42):18115-20. doi: 10.1073/pnas.1006732107. Epub 2010 Oct 4.

17.

Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.

Shimono Y, Zabala M, Cho RW, Lobo N, Dalerba P, Qian D, Diehn M, Liu H, Panula SP, Chiao E, Dirbas FM, Somlo G, Pera RA, Lao K, Clarke MF.

Cell. 2009 Aug 7;138(3):592-603. doi: 10.1016/j.cell.2009.07.011.

18.

Cancer stem cells and tumor metastasis: first steps into uncharted territory.

Dalerba P, Clarke MF.

Cell Stem Cell. 2007 Sep 13;1(3):241-2. doi: 10.1016/j.stem.2007.08.012.

19.

The 5th International Society for Stem Cell Research (ISSCR) Annual Meeting, June 2007.

Rajasekhar VK, Dalerba P, Passegué E, Lagasse E, Najbauer J.

Stem Cells. 2008 Jan;26(1):292-8. Epub 2007 Oct 25.

20.

Phenotypic characterization of human colorectal cancer stem cells.

Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, Shelton AA, Parmiani G, Castelli C, Clarke MF.

Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10158-63. Epub 2007 Jun 4.

21.

Identification of pancreatic cancer stem cells.

Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF, Simeone DM.

Cancer Res. 2007 Feb 1;67(3):1030-7.

22.

The prognostic role of a gene signature from tumorigenic breast-cancer cells.

Liu R, Wang X, Chen GY, Dalerba P, Gurney A, Hoey T, Sherlock G, Lewicki J, Shedden K, Clarke MF.

N Engl J Med. 2007 Jan 18;356(3):217-26.

23.

Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma.

Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF, Ailles LE.

Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):973-8. Epub 2007 Jan 8.

24.

Cancer stem cells: models and concepts.

Dalerba P, Cho RW, Clarke MF.

Annu Rev Med. 2007;58:267-84. Review.

PMID:
17002552
25.

Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: evidence against immortality as a constitutive trait of tumor cells.

Dalerba P, Guiducci C, Poliani PL, Cifola I, Parenza M, Frattini M, Gallino G, Carnevali I, Di Giulio I, Andreola S, Lombardo C, Rivoltini L, Schweighoffer T, Belli F, Colombo MP, Parmiani G, Castelli C.

Cancer Res. 2005 Mar 15;65(6):2321-9.

26.

Antigen-specific immunity in neuroblastoma patients: antibody and T-cell recognition of NY-ESO-1 tumor antigen.

Rodolfo M, Luksch R, Stockert E, Chen YT, Collini P, Ranzani T, Lombardo C, Dalerba P, Rivoltini L, Arienti F, Fossati-Bellani F, Old LJ, Parmiani G, Castelli C.

Cancer Res. 2003 Oct 15;63(20):6948-55.

27.

The apoptosis inhibitor protein survivin induces tumor-specific CD8+ and CD4+ T cells in colorectal cancer patients.

Casati C, Dalerba P, Rivoltini L, Gallino G, Deho P, Rini F, Belli F, Mezzanzanica D, Costa A, Andreola S, Leo E, Parmiani G, Castelli C.

Cancer Res. 2003 Aug 1;63(15):4507-15.

28.

Immunology and immunotherapy of colorectal cancer.

Dalerba P, Maccalli C, Casati C, Castelli C, Parmiani G.

Crit Rev Oncol Hematol. 2003 Apr;46(1):33-57. Review.

PMID:
12672517
29.

Immunity to cancer: attack and escape in T lymphocyte-tumor cell interaction.

Rivoltini L, Carrabba M, Huber V, Castelli C, Novellino L, Dalerba P, Mortarini R, Arancia G, Anichini A, Fais S, Parmiani G.

Immunol Rev. 2002 Oct;188:97-113. Review.

PMID:
12445284
30.

Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?

Parmiani G, Castelli C, Dalerba P, Mortarini R, Rivoltini L, Marincola FM, Anichini A.

J Natl Cancer Inst. 2002 Jun 5;94(11):805-18. Review.

PMID:
12048268
31.

T cell response to tumor antigens and its therapeutic use in cancer patients.

Parmiani G, Castelli C, Dalerba P, Rivoltini L.

Adv Exp Med Biol. 2001;495:403-10. No abstract available.

PMID:
11774601
32.

MAGE, BAGE and GAGE gene expression in human rhabdomyosarcomas.

Dalerba P, Frascella E, Macino B, Mandruzzato S, Zambon A, Rosolen A, Carli M, Ninfo V, Zanovello P.

Int J Cancer. 2001 Jul 1;93(1):85-90.

33.

MAGE, BAGE, and GAGE gene expression in patients with esophageal squamous cell carcinoma and adenocarcinoma of the gastric cardia.

Zambon A, Mandruzzato S, Parenti A, Macino B, Dalerba P, Ruol A, Merigliano S, Zaninotto G, Zanovello P.

Cancer. 2001 May 15;91(10):1882-8.

PMID:
11346870
34.

Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response.

Russo V, Tanzarella S, Dalerba P, Rigatti D, Rovere P, Villa A, Bordignon C, Traversari C.

Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2185-90.

35.

Identification of a promiscuous T-cell epitope encoded by multiple members of the MAGE family.

Tanzarella S, Russo V, Lionello I, Dalerba P, Rigatti D, Bordignon C, Traversari C.

Cancer Res. 1999 Jun 1;59(11):2668-74.

36.

The DAM gene family encodes a new group of tumor-specific antigens recognized by human leukocyte antigen A2-restricted cytotoxic T lymphocytes.

Fleischhauer K, Gattinoni L, Dalerba P, Lauvau G, Zanaria E, Dabovic B, van Endert PM, Bordignon C, Traversari C.

Cancer Res. 1998 Jul 15;58(14):2969-72.

38.

MAGE BAGE and GAGE genes expression in fresh epithelial ovarian carcinomas.

Russo V, Dalerba P, Ricci A, Bonazzi C, Leone BE, Mangioni C, Allavena P, Bordignon C, Traversari C.

Int J Cancer. 1996 Jul 29;67(3):457-60. No abstract available.

Supplemental Content

Loading ...
Support Center